Abstract:Background: Mismatch repair deficiency (dMMR) due to germline mutations in DNA repair genes including MLH1, MSH2, MSH6 and PMS2, or somatic aberrant silencing of MLH1, is a well-established feature for Lynch syndrome, a major type of hereditary colorectal cancer (CRC). The purpose of this study is to derive prevalence of germline MMR gene mutations in Chinese population with dMMR CRC. Methods: ColonCore panel is designed for simultaneous detection of microsatellite instabiligy (MSI) status of 22 regions and mutations in 38 CRC-related genes. Whole exons of the 38 genes were covered by the panel. The MSI phenotype detection method was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. Results: Among 1394 postsurgical CRC patients whose MMR status were detected by immunohistochemistry (IHC), 99 patients were dMMR, accounting for 7.1%. The concordance rate was 92.3% between MSI and IHC. Next, we investigated the germline mutation spectrum of dMMR patients. About 26.3% patients harbored pathogenic germline MMR gene mutations, with 13%, 6%, 5% and 2% of patients carrying pathogenic MLH1, MSH2, MSH6 and PMS2 mutations, respectively. Specially, about 30% pathogenic MLH1 mutation occured in splice region. Among patients with pathogenic MMR gene mutations, their first cancer was diagnosed ranging from 22 to 69 years old with median age at diagnosis was 50, and only 57% have a family history of ≥ 1 relative with Lynch syndrome related cancers. Furthermore, 3% harbored pathogenic mutations in other genes. Approximately, 17% of patients harbored MMR gene variants of unknown significance (VUS) and 26% harbored other VUS. The remaining 28% of patients had no pathogenic or VUS mutations from this panel. Conclusions: The prevalence rate of germline pathogenic mutations is 26% in dMMR CRC patients, accounting for 1.8% of all resectable CRC patients. Median age at diagnosis of Lynch syndrome related cancers is 50 years old and nearly 40% Lynch syndrome patients have no family history. Legal entity responsible for the study: Ying Yuan. Funding: Burning Rock Biotech. Disclosure: C. Liu: Burning Rock Biotech. All other authors have declared no conflicts of interest.

Mouse models of DNA mismatch repair in cancer research

Mouse Models for Human DNA Mismatch-Repair Gene Defects.

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

Single-cell whole-genome sequencing reveals mutational landscapes of DNA mismatch repair deficiency in mouse primary fibroblasts

Modeling the Etiology of p53-mutated Cancer Cells

Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer

Modifiers of Expression in Mutations of Mismatch Repair Gene Carriers in Hereditary Nonpolyposis Colorectal Cancer

Spontaneous Intestinal Carcinomas and Skin Neoplasms in Msh2-deficient Mice.

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer

Analysis of Human MutS Homolog 2 Missense Mutations in Patients with Colorectal Cancer

[Mutation of Human Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Families].

The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

Mlh1 Mediates Tissue-Specific Regulation of Mitotic Recombination

Mouse Models of BRCA1 and Their Application to Breast Cancer Research

Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer.

Data from The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

Msh2 Deficiency Contributes to Accelerated Apc-Mediated Intestinal Tumorigenesis

If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers

Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations